Home
Michael Thomas Henderson, CEO: Apogee Therapeutics APGE Sell · Filed 06/12
Trade details
- Type
- Insider sale
- Amount
- $633,598.12
- Shares · price
- 7,654 sh · $82.78 a share
- Held after
- 1,101,563 sh
- Trade date
- 26/06/10
- Filed
- 26/06/12
- Days to filing
- 2 days
Sold 0.7% of holdings
- Share of holding sold
- 0.7%
Apogee Therapeutics trades, last 26 weeks
What else happened in Apogee Therapeutics around then
Filed or reported within 30 days of the trade day · 05/11~07/10Michael Thomas Henderson's recent trades
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$10.6M
80,000 sh
$10.6M
Filed 06/24
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 planSpyre Therapeutics
SYRE
$2M
20,000 sh
$2M
Filed 06/23
Traded 06/22
- Michael Thomas Henderson
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 planSpyre Therapeutics
SYRE
$1.8M
20,000 sh
$1.8M
Filed 06/22
Traded 06/22
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$556.6K
6,770 sh
$556.6K
Filed 06/12
Traded 06/10
- Michael Thomas Henderson
Sell10b5-1 planApogee Therapeutics
Sell10b5-1 planApogee Therapeutics
APGE
$198.9K
2,305 sh
$198.9K
Filed 06/12
Traded 06/10
